arrow
D

Damian Wild

University Hospital Basel and University of Basel
H指数:43
被引数:7,057

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beta2-adrenergic stimulation by fenoterol increases energy expenditure without activating human brown adipose tissue

芬特诺尔通过β2肾上腺素能刺激增加能量消耗而不激活人棕色脂肪组织

2026-08-120
OA
Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study

放射性标记的生长抑素受体拮抗剂与激动剂在转移性嗜铬细胞瘤或副神经节瘤患者肽受体放射性核素治疗中的比较:一项回顾性试点研究

2026-08-120
OA
Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumours

在表达生长抑素受体的肿瘤患者中,与标准肽受体放射性核素治疗相比,使用放射性标记的生长抑素受体拮抗剂可提高无进展生存期。

2026-03-240
PRE
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study

Hepprich, M.; Romberg, C.; Mudry, J.; Refardt, J.; Wild, D.; Antwi, K.; Christ, E. 依克那肽用于诊断内源性高胰岛素血症性低血糖:一项随机安慰剂对照、双盲、交叉设计的原则验证研究。Eur. J. Endocrinol. 2025, 193, 247–254. [Google Scholar] [CrossRef]

2025-08-011
OA
First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study

首次人体给药的[⁶¹Cu]Cu-NODAGA-LM3及其与[⁶⁸Ga]Ga-DOTA-TOC PET/CT的头对头比较,作为NET研究中的COPPER PET I/II期试验的一部分

2025-05-240
OA
Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (82Rb-PET)

评估三种诊断算法在减少疑似慢性冠状动脉综合征并接受82Rb-正电子发射断层扫描(82Rb-PET)患者中正常扫描率、辐射暴露和成本的效果。

2025-01-110
OA
First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study
2024-12-050
OAAI
Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks (vol 15, 8402, 2024)

利用卷积神经网络从CT扫描中预测棕色脂肪组织的标准化摄取值(vol 15, 8402, 2024)

2024-11-190
OA
Improved Localization of Insulinomas Using 68 Ga-NODAGA-Exendin-4 PET/CT
2024-10-170
OAAI
Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks

使用卷积神经网络从CT扫描预测棕色脂肪组织的标准化摄取值

2024-09-271
OA
Single-nucleus transcriptomics identifies separate classes of UCP1 and futile cycle adipocytes

单核转录组学鉴定UCP1和无用周期脂肪细胞的独立课程

2024-09-012
OAAI
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours
2024-03-264
OAAI
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
2024-03-077
OAAI